AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 126 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $46 | -16.4% | 50,633 | -48.3% | 0.00% | -33.3% |
Q1 2023 | $55 | -99.9% | 97,854 | -25.3% | 0.01% | -14.3% |
Q1 2022 | $94,000 | -46.3% | 130,949 | +183.0% | 0.01% | -58.8% |
Q2 2021 | $175,000 | -68.4% | 46,270 | -71.7% | 0.02% | -56.4% |
Q1 2021 | $554,000 | +167.6% | 163,532 | +98.7% | 0.04% | +8.3% |
Q3 2020 | $207,000 | +68.3% | 82,303 | +322.3% | 0.04% | +200.0% |
Q4 2019 | $123,000 | +66.2% | 19,491 | +2.9% | 0.01% | +100.0% |
Q3 2019 | $74,000 | -52.6% | 18,948 | -32.8% | 0.01% | -25.0% |
Q4 2018 | $156,000 | +54.5% | 28,181 | +179.1% | 0.01% | +100.0% |
Q2 2018 | $101,000 | -54.7% | 10,097 | -56.8% | 0.00% | -66.7% |
Q1 2018 | $223,000 | +21.2% | 23,352 | +88.5% | 0.01% | +20.0% |
Q4 2017 | $184,000 | -9.8% | 12,387 | +19.4% | 0.01% | 0.0% |
Q3 2017 | $204,000 | – | 10,372 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 3,100,000 | $15,004,000 | 2.10% |
DAFNA Capital Management LLC | 830,538 | $4,020,000 | 1.51% |
Baupost Group | 24,471,453 | $118,442,000 | 1.07% |
Nantahala Capital Management | 5,789,561 | $28,021,000 | 0.86% |
Old West Investment Management, LLC | 367,870 | $1,780,000 | 0.84% |
Abrams Capital Management | 5,656,462 | $27,377,000 | 0.74% |
Sofinnova Investments, Inc. | 848,356 | $4,106,000 | 0.38% |
Stanley-Laman Group, Ltd. | 312,609 | $1,513,000 | 0.36% |
Nantahala Capital Management | 2,000,000 | $9,680,000 | 0.30% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,494,070 | $7,231,000 | 0.24% |